Safe Work Laboratories Pty Ltd

Safework Health

Site

Safe Work Laboratories Pty Ltd – Brisbane

Safework Health

Accreditation No.

18874

Site No.

24739

Date of Accreditation

21 Oct 2019

Address

4/57 Miller St
Murarrie, QLD 4172
Australia

safeworkhealth.com.au

Contact

Ms Natasha Laugier P: +61 (07) 35523001

Availability

Services available to external clients

Safe Work Laboratories Pty Ltd address map

Scope of Accreditation

Print scopes
Safe Work Laboratories Pty Ltd – Brisbane

ISO/IEC 17025 (2017)

Human Testing for Workplace and/or Community Screening

Service Product Determinant Technique Procedure
Monitoring for residues, hydrocarbons and other contaminants of the environment (excluding pesticides) Urine Phenol GC-MS in-house method LAB - WI - 5631 - SWL - Phenol in Urine GCMS Method
Isocyanates; s-Phenyl mercapturic acid LC-MS-MS in-house method LAB - WI - 5657 - SWL - Isocyanate Exposure in Urine LCMS Method
In-house method LABWI - 19626 – SWL - Benzene Exposure Analysis in Urine - LC/MS/MS Method

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Analysis for sports drugs and drug metabolites Human urine Salbutamol
Medico legal drug testing AS/NZS 4308:2008, appendix A On-site screening procedure Urine Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates
Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch Urine Colour; Creatinine; Oxidants; Specific gravity; Temperature; pH
Medico legal drug testing AS/NZS 4308:2008, section 3 General laboratory requirements Urine General laboratory requirements as described in AS/NZS 4308
Medico legal drug testing AS/NZS 4308:2008, section 4 Laboratory screening procedures Urine Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates
Medico legal drug testing AS/NZS 4308:2008, section 5 Laboratory confirmatory procedures Urine 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; 6-Acetylmorphine; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Codeine; Diazepam; Ecgonine methyl ester; Ephedrine; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Nordiazepam; Oxazepam; Phentermine; Pseudoephedrine (PSE); Temazepam; α-Hydroxyalprazolam
Fentanyl; Norfentanyl; Noroxycodone; Oxycodone
Medico legal drug testing AS/NZS 4308:2023, Appendix A, Additional and optional testing Urine 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); 6-Acetylmorphine; Buprenorphine; Diazepam; Ecgonine methyl ester; Ephedrine; Fentanyl; Ketamine; N-Desmethyl cis tramadol; Norbuprenorphine; Norfentanyl; Norketamine; Noroxycodone; Oxycodone; Phentermine; Pseudoephedrine (PSE); Tramadol
Medico legal drug testing AS/NZS 4308:2023, Section 2 Specimen collection, storage, handling and dispatch Urine Colour; Creatinine; Oxidants; Specific gravity; Temperature; pH
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Tetrahydrocannabinol (THC) metabolites
Medico legal drug testing AS/NZS 4308:2023, Section 4 General laboratory requirements Urine General laboratory requirements as described in AS/NZS 4308
Medico legal drug testing AS/NZS 4308:2023, Section 5 Laboratory screening procedures Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Tetrahydrocannabinol (THC) metabolites
Medico legal drug testing AS/NZS 4308:2023, Section 6 Laboratory confirmatory procedures Urine 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamine; Benzoylecgonine (ecgonine benzoate); Carboxy-tetrahydrocannabinol (THC-COOH); Codeine; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Nordiazepam; Oxazepam; Temazepam; α-Hydroxyalprazolam
Medico legal drug testing AS/NZS 4760, appendix B Additional testing Oral fluid Alprazolam; Clonazepam; Diazepam; Fentanyl; Flunitrazepam; Ketamine; Nitrazepam; Nordiazepam; Oxazepam; Phentermine; Temazepam; Tramadol
Medico legal drug testing AS/NZS 4760, section 2 Collection, storage, handling and dispatch Oral fluid Handling and dispatch; Sample collection and storage
Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures Oral fluid 6-Acetylmorphine; Amphetamine; Benzoylecgonine (ecgonine benzoate); Cocaine; Codeine; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Oxycodone; Δ-9-Tetrahydrocannabinol (THC-Δ9)
Quantitative analysis of non-animal/non-human samples for drugs and other substances Filters; Swabs; Wipes Amphetamine; Ephedrine; Methamphetamine; Pseudoephedrine (PSE)
Client Sites

ISO/IEC 17025 (2017)

Legal

Service Product Determinant
Medico legal drug testing AS/NZS 4308:2008, appendix A On-site screening procedure - Testing performed at client sites Urine Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Creatinine; Opiates
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at client sites Urine Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Tetrahydrocannabinol (THC) metabolites

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.